Pterostilbene Cocrystals for Improved Water Solubility

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Pterostilbene's low water solubility poses a challenge for its bioavailability, necessitating the development of more soluble solid forms to enhance pharmaceutical properties.

Innovation Solution

Formation of cocrystals with coformers capable of forming hydrogen bond interactions, such as picolinic acid, 1,4-dimethylpiperazine, and others, to improve water solubility and dissolution rate.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If pterostilbene is used in its conventional crystalline solid form, then it maintains structural stability, but its water solubility remains low which limits bioavailability

Engineering Contradiction:
ImprovebioavailabilityVSAvoidwater solubility
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent applies cocrystal formation by combining pterostilbene with coformers (such as aromatic carboxylic acids, heterocyclic compounds, or amino acids) to create a composite solid material. This cocrystal structure maintains the stability of pterostilbene while incorporating coformers that enhance water solubility and dissolution rate, thereby improving bioavailability without sacrificing structural integrity

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent changes the physical and chemical parameters of pterostilbene by forming cocrystals with different coformers, resulting in solid forms with modified solubility characteristics. By selecting appropriate coformers with specific functional groups capable of hydrogen bonding, the dissolution rate and water solubility parameters are improved while maintaining the active ingredient's stability

Inventive Principle:
Principle #35Parameter changes

2Quantity of substance

If cocrystal formation is attempted to improve solubility, then water solubility and dissolution rate increase, but the process requires significant time, effort and resources to find appropriate coformers and conditions

Engineering Contradiction:
Improvewater solubilityVSAvoiddevelopment time
Core Design Contradiction:
Quantity of substanceVSLoss of time

Solution Approach 1:

The patent systematically varies parameters such as coformer selection (different functional groups), solvent types, temperature, and mixing ratios to identify optimal cocrystal formation conditions. This structured parameter exploration accelerates the discovery process by focusing on promising coformer classes rather than exhaustive screening

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses screening methodologies and solubility assessment tools as intermediaries to evaluate potential cocrystal systems efficiently. These intermediaries provide rapid feedback on solubility improvements, allowing researchers to identify successful cocrystal formulations without extensive optimization work

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The cocrystals exhibit enhanced water solubility and bioavailability, making them suitable for pharmaceutical and dietary compositions.

Implementation Method 1

a cocrystal of pterostilbene and a coformer capable to form hydrogen bond interactions

Methodology Applied
Scientific EffectHydrogen bond interactions: Chemical Bonding

Data Source

PatentUS12595220B2Cocrystals of pterostilbene and compositions comprising them
Publication Date: 2026.04.07 CENT FOR INTELLIGENT RES IN CRYSTAL ENG SL
  • US12595220B2 patent drawing
  • US12595220B2 patent drawing
  • US12595220B2 patent drawing

AI summary

The present disclosure relates to a cocrystal of pterostilbene and a coformer capable to form hydrogen bond interactions, to a process for the preparation thereof, and to its use as a medicament or a dietary supplement. The present disclosure also relates to a composition comprising the cocrystal.